Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

522
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
522

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using Machine Learning to Revise the AJCC Staging System for Neuroendocrine Tumors of the Pancreas.

Cancers·2025
Same author

Using Machine Learning to Create Prognostic Systems for Primary Prostate Cancer.

Diagnostics (Basel, Switzerland)·2025
Same author

Ten-Year Trends in Digital Rectal Exam Results and Prostate Cancer Detection: Insights from the PLCO Trial.

Research and reports in urology·2025
Same author

A Five-Gene Signature for the Prediction of Event-Free Survival of Both Pediatric and Adult Acute Myeloid Leukemia.

Diagnostics (Basel, Switzerland)·2025
Same author

Integrating additional factors into the TNM staging for cutaneous melanoma by machine learning.

PloS one·2021
Same author

Expanding TNM for lung cancer through machine learning.

Thoracic cancer·2021

Related Experiment Video

Updated: Nov 15, 2025

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

330

A prognostic system for epithelial ovarian carcinomas using machine learning.

Philip M Grimley1, Zhenqiu Liu2, Kathleen M Darcy3

  • 1Department of Pathology, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.

Acta Obstetricia Et Gynecologica Scandinavica
|March 5, 2021
PubMed
Summary
This summary is machine-generated.

Machine learning improved epithelial ovarian carcinoma staging by integrating additional factors like age and histology, enhancing survival prediction accuracy beyond the traditional FIGO system.

Keywords:
C-indexdendrogrammachine learningovarian carcinomastagingsurvival

More Related Videos

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.5K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

7.0K

Related Experiment Videos

Last Updated: Nov 15, 2025

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

330
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.5K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

7.0K

Area of Science:

  • Oncology
  • Machine Learning
  • Biostatistics

Background:

  • Accurate patient classification and survival prediction in epithelial ovarian carcinoma (EOC) necessitate integrating additional prognostic factors into the International Federation of Gynecology and Obstetrics (FIGO) staging system.
  • Machine learning (ML) offers a novel approach to incorporate these parameters for improved patient stratification.

Purpose of the Study:

  • To evaluate the efficacy of ML, specifically the Ensemble Algorithm for Clustering Cancer Data (EACCD), in enhancing the FIGO staging system for EOC.
  • To assess the impact of incorporating additional prognostic parameters (age, histology, grade) on survival prediction accuracy.

Main Methods:

  • EOC survival data were obtained from the Surveillance, Epidemiology, and End Results (SEER) program.
  • Two datasets were created: Dataset 1 (TNM criteria) and Dataset 2 (TNM + Age + Histology/Grade).
  • The EACCD algorithm was applied to stratify patients into prognostic groups, with accuracy assessed using C-indices.

Main Results:

  • The EACCD system stratified Dataset 1 into nine prognostic groups, showing slightly higher survival prediction accuracy (C-index=0.7391) than the FIGO system (C-index=0.7371).
  • Integration of age and histology/grade in Dataset 2 resulted in nine prognostic groups with significantly improved prediction accuracy (C-index=0.7605).
  • A strong association was observed between EACCD and FIGO staging systems (rank correlation=0.9480).

Conclusions:

  • EACCD effectively integrates additional prognostic factors (age, histology) with TNM criteria for improved stratification and survival prediction in EOC.
  • This ML-driven approach facilitates the incorporation of emerging diagnostic and therapeutic advances to refine prognostic assessments.